Cancer Aging and Radiopharmaceuticals

Currently, the radiopharmaceuticals market is expanding rapidly. Advancements in science, an aging population, and higher rates of cancer are all playing a role in the equation, and companies looking to assist those in need have ample opportunities to expand. Here’s a look at the radiopharmaceuticals market, including its projected growth, what’s spurring the rise in interest, and more. Numbers and Projections While radiopharmaceuticals is a relatively new life sciences field, it’s attracted a significant amount of attention. Ultimately, the possible applications have considerable potential in the world of healthcare, and that’s spurring rapid growth. The radiopharmaceuticals market has been trending upward. Between 2017 and 2022, the market went from $3.9 billion to $5.2 billion. Based on a predicted compounded annual growth rate of 10.2 percent, it’s set to cross $13.67 billion by 2032. Cancer, Aging, and Radiopharmaceuticals As mentioned previously, part of what’s spurring growth in the radiopharmaceuticals market is rising occurrences of ......